You are here

ISIS-CRPRx

Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape

Motley Fool

Wed, 08/7/13 - 10:14 am

Isis Pharmaceuticals

Isis to stop developing rheumatoid arthritis drug

Reuters

Mon, 08/5/13 - 09:54 am

Isis Pharmaceuticals

rheumatoid arthritis